WallStreetZenWallStreetZen

NASDAQ: MRVI
Maravai Lifesciences Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MRVI

Based on 3 analysts offering 12 month price targets for Maravai Lifesciences Holdings Inc

Min Forecast
$5.50-29.58%
Avg Forecast
$6.67-14.64%
Max Forecast
$8.00+2.43%

Should I buy or sell MRVI stock?

Based on 3 analysts offering ratings for Maravai Lifesciences Holdings Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MRVI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MRVI as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their MRVI stock forecasts and price targets.

MRVI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-09
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-05-08

1 of 1

Forecast return on equity

Is MRVI forecast to generate an efficient return?

Company
-11.65%
Industry
21.35%
Market
172.15%
MRVI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MRVI forecast to generate an efficient return on assets?

Company
-3.95%
Industry
21.87%
MRVI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MRVI earnings per share forecast

What is MRVI's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$0.11
Avg 2 year Forecast
-$0.10
Avg 3 year Forecast
-$0.09

MRVI revenue forecast

What is MRVI's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$216.0M+3.46%
Avg 2 year Forecast
$229.4M+9.89%
Avg 3 year Forecast
$246.3M+17.95%
MRVI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MRVI revenue growth forecast

How is MRVI forecast to perform vs Biotechnology companies and vs the US market?

Company
5.56%
Industry
30.08%
Market
12.75%
MRVI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MRVI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MRVI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MRVI$7.81$6.67-14.64%Strong Buy
ZYME$28.61$39.71+38.81%Strong Buy
SEPN$44.00$52.43+19.16%Strong Buy
FTRE$21.29$24.00+12.73%Strong Buy
VCEL$40.26$60.67+50.69%Strong Buy
View Top Biotech Stocks

Maravai Lifesciences Holdings Stock Forecast FAQ

Is Maravai Lifesciences Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: MRVI) stock is to Strong Buy MRVI stock.

Out of 3 analysts, 2 (66.67%) are recommending MRVI as a Strong Buy, 0 (0%) are recommending MRVI as a Buy, 1 (33.33%) are recommending MRVI as a Hold, 0 (0%) are recommending MRVI as a Sell, and 0 (0%) are recommending MRVI as a Strong Sell.

If you're new to stock investing, here's how to buy Maravai Lifesciences Holdings stock.

What is MRVI's earnings growth forecast for 2026-2028?

(NASDAQ: MRVI) Maravai Lifesciences Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.44%.

Maravai Lifesciences Holdings's earnings in 2026 is -$77,386,000.On average, 11 Wall Street analysts forecast MRVI's earnings for 2026 to be -$28,538,131, with the lowest MRVI earnings forecast at -$38,172,023, and the highest MRVI earnings forecast at -$21,812,585. On average, 11 Wall Street analysts forecast MRVI's earnings for 2027 to be -$26,382,840, with the lowest MRVI earnings forecast at -$50,896,031, and the highest MRVI earnings forecast at -$4,362,517.

In 2028, MRVI is forecast to generate -$23,188,855 in earnings, with the lowest earnings forecast at -$43,261,626 and the highest earnings forecast at $5,453,146.

What is MRVI's revenue growth forecast for 2026-2028?

(NASDAQ: MRVI) Maravai Lifesciences Holdings's forecast annual revenue growth rate of 5.56% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 29.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.61%.

Maravai Lifesciences Holdings's revenue in 2026 is $208,775,000.On average, 11 Wall Street analysts forecast MRVI's revenue for 2026 to be $56,089,503,000, with the lowest MRVI revenue forecast at $53,568,072,101, and the highest MRVI revenue forecast at $58,104,570,330. On average, 11 Wall Street analysts forecast MRVI's revenue for 2027 to be $59,574,323,048, with the lowest MRVI revenue forecast at $55,551,978,596, and the highest MRVI revenue forecast at $62,576,150,153.

In 2028, MRVI is forecast to generate $63,947,226,893 in revenue, with the lowest revenue forecast at $59,496,420,960 and the highest revenue forecast at $69,109,538,558.

What is MRVI's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MRVI) forecast ROA is -3.95%, which is lower than the forecast US Biotechnology industry average of 21.83%.

What is MRVI's Price Target?

According to 3 Wall Street analysts that have issued a 1 year MRVI price target, the average MRVI price target is $6.67, with the highest MRVI stock price forecast at $8.00 and the lowest MRVI stock price forecast at $5.50.

On average, Wall Street analysts predict that Maravai Lifesciences Holdings's share price could fall to $6.67 by Sep 9, 2027. The average Maravai Lifesciences Holdings stock price prediction forecasts a potential downside of 14.64% from the current MRVI share price of $7.81.

What is MRVI's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MRVI) Maravai Lifesciences Holdings's current Earnings Per Share (EPS) is -$0.52. On average, analysts forecast that MRVI's EPS will be -$0.11 for 2026, with the lowest EPS forecast at -$0.15, and the highest EPS forecast at -$0.08. On average, analysts forecast that MRVI's EPS will be -$0.10 for 2027, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at -$0.02. In 2028, MRVI's EPS is forecast to hit -$0.09 (min: -$0.17, max: $0.02).

What is MRVI's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MRVI) forecast ROE is -11.65%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.